We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
-7.52%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$250M
AUM Growth
-$48.9M
Cap. Flow
-$2.79M
Cap. Flow %
-1.12%
Top 10 Hldgs %
27.41%
Holding
148
New
29
Increased
17
Reduced
14
Closed
22

Top Buys

Rank Stock Value
1
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$7.25M
2
GH icon
Guardant Health
GH
+$5.2M
3
STAA icon
STAAR Surgical
STAA
+$4.83M
4
INGN icon
Inogen
INGN
+$4.14M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$3.53M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$7.56M
2
PEPLU
PepperLime Health Acquisition Corporation Unit
PEPLU
+$7.23M
3
GMED icon
Globus Medical
GMED
+$5.83M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$5.82M
5
BCYC
Bicycle Therapeutics
BCYC
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 73.54%
2 Financials 11.69%
3 Industrials 1.28%
4 Technology 0.99%
5 Consumer Discretionary 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMTXW
101
DELISTED
Immatics N.V. Warrants
IMTXW
$199K 0.08%
97,467
– –
DBGI
102
Digital Brands Group
DBGI
$8.41M
– –
0
– –
BBIO icon
103
CALL
BridgeBio Pharma
BBIO
$16.2B
$158K 0.06%
+17,400
New +$146K
HCDIW
104
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$116K 0.05%
600,000
– –
OBIO icon
105
Orchestra BioMed
OBIO
$249M
$100K 0.04%
10,000
– –
CINGW icon
106
Cingulate Inc Warrants
CINGW
$35.4K
$85K 0.03%
270,000
– –
PEPLW
107
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$76K 0.03%
367,500
– –
DRCTW
108
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$70K 0.03%
180,000
– –
SONX
109
DELISTED
Sonendo, Inc.
SONX
$65K 0.03%
+37,572
New +$100K
NXGLW icon
110
NexGel Inc Warrant
NXGLW
$63K 0.03%
225,000
– –
BNCWW
111
CEA Industries Inc Warrant
BNCWW
$44.7K
$60K 0.02%
250,000
– –
RCOR.WS
112
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$51K 0.02%
731,561
– –
LAAAW
113
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$27K 0.01%
150,000
– –
NLSPW
114
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$24K 0.01%
200,000
– –
MBTCR
115
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$20K 0.01%
500,000
– –
SRZNW icon
116
Surrozen Inc Warrant
SRZNW
$22.4K
$16K 0.01%
82,233
– –
MOBXW icon
117
Mobix Labs Warrants
MOBXW
$752K
$11K ﹤0.01%
150,000
– –
OHAAW
118
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$9K ﹤0.01%
50,000
– –
EUCRW
119
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$9K ﹤0.01%
133,333
– –
TMPMW
120
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$8K ﹤0.01%
84,666
– –
ADRT.WS
121
DELISTED
Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
ADRT.WS
$7K ﹤0.01%
112,500
– –
SRSAW
122
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$6K ﹤0.01%
75,000
– –
GIWWW
123
DELISTED
GigInternational1, Inc. Warrant
GIWWW
$4K ﹤0.01%
50,000
– –
AXH.WS
124
DELISTED
Industrial Human Capital, Inc. Warrants
AXH.WS
$4K ﹤0.01%
100,000
– –
MITAW
125
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$3K ﹤0.01%
28,333
– –
2 3 4
5
6

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return

Altium Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Altium Capital Management held 148 positions worth $250M, down 16% from $299M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Altium Capital Management's Q2 2022 filing shows 29 new, 17 increased, 14 reduced and 22 closed positions. Its largest new stake was PepperLime Health Acquisition Corporation Class A Ordinary Share: 735,000 shares worth $7.25M. The largest sale was Esperion Therapeutics, an estimated $7.56M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 78% a quarter earlier, followed by Financials and Industrials.

  • Altium Capital Management's largest Q2 2022 buy was PepperLime Health Acquisition Corporation Class A Ordinary Share: 735,000 shares worth $7.25M.
  • Altium Capital Management added most to Lantheus in Q2 2022, an estimated $3.03M increase.
  • Altium Capital Management's biggest Q2 2022 reduction was Esperion Therapeutics, cutting an estimated $7.56M.
  • Altium Capital Management fully exited PepperLime Health Acquisition Corporation Unit in Q2 2022, selling an estimated $7.23M.
  • Altium Capital Management's ten largest holdings make up 27% of its $250M portfolio in Q2 2022.
  • Altium Capital Management opened 29 new positions and closed 22 in Q2 2022.
  • Altium Capital Management's portfolio value fell 16% quarter-over-quarter to $250M.

Based on Altium Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.